New Key Statistics Module, Z-Score and F-Score
NAS:PRQR Key Ratios
| Market Cap $ M | 282.77 |
| Enterprise Value $ M | 205.62 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | 7.88 |
| Price/Sales | 11.22 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 19.00 |
| EPS (TTM) $ | -0.32 |
| Beneish M-Score | 0.11 |
| 10-y EBITDA Growth Rate % | 0.40 |
| 5-y EBITDA Growth Rate % | 20.80 |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -8.65 |
| EV-to-EBITDA | -9.94 |
| PEG | -- |
| Shares Outstanding M | 105.91 |
| Net Margin (%) | -134.57 |
| Operating Margin % | -167.84 |
| Pre-tax Margin (%) | -135.63 |
| Quick Ratio | 2.33 |
| Current Ratio | 2.33 |
| ROA % (ttm) | -19.20 |
| ROE % (ttm) | -67.00 |
| ROIC % (ttm) | -60.94 |
| Dividend Yield % | -- |
| Altman Z-Score | -3.59 |
PRQR Number of Guru Trades
PRQR Volume of Guru Trades
Gurus Latest Trades with NAS:PRQR
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:PRQR is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
ProQR Therapeutics NV Insider Transactions
No Available Data
News about NAS:PRQR
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers